XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 1 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $819,000 | -40.8% | 334,367 | -1.7% | 0.07% | -23.9% |
| Q2 2021 | $1,384,000 | +2.8% | 340,147 | +14.0% | 0.09% | -9.3% |
| Q1 2021 | $1,346,000 | +9.1% | 298,385 | +19.0% | 0.10% | -5.8% |
| Q4 2020 | $1,234,000 | +0.4% | 250,798 | +21.0% | 0.10% | -16.3% |
| Q3 2020 | $1,229,000 | +184.5% | 207,210 | +27.7% | 0.12% | +108.5% |
| Q2 2020 | $432,000 | +63.6% | 162,305 | +20.0% | 0.06% | +55.3% |
| Q1 2020 | $264,000 | -58.7% | 135,255 | +49.2% | 0.04% | -50.0% |
| Q4 2019 | $639,000 | +13.9% | 90,675 | +59.0% | 0.08% | 0.0% |
| Q3 2019 | $561,000 | +19.9% | 57,028 | +39.4% | 0.08% | +11.8% |
| Q2 2019 | $468,000 | +175.3% | 40,914 | +141.8% | 0.07% | +142.9% |
| Q1 2019 | $170,000 | – | 16,920 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|